```html

Nicotine Poisoning (Nicotine Toxicity)

Overview

Nicotine poisoning, also called nicotine toxicity, occurs when a person is exposed to a dose of nicotine that exceeds the body’s ability to metabolize and eliminate it. While nicotine is most commonly associated with cigarettes and e‑cigarettes, any product that contains the alkaloid—such as nicotine gum, patches, lozenges, liquid nicotine for vaping, or even certain insecticides—can cause toxicity if misused or accidentally ingested.

Although fatal nicotine poisoning is rare in the United States, CDC estimates that >30 % of unintentional poison exposures in children under five involve nicotine‑containing products. In adults, the majority of cases result from accidental oral ingestion of e‑liquid or intentional overdose in suicide attempts.

Who is affected?

• Children—especially toddlers who explore objects by putting them in their mouths.
• Adolescents and young adults—frequent users of vaping devices who may mishandle concentrated nicotine solutions.
• Workers—people handling nicotine in industrial settings (e.g., pesticide manufacturers) without proper protective equipment.
• Individuals attempting self‑harm—intentional ingestion of nicotine products.

Exact prevalence is hard to pinpoint because many mild cases are never reported, but the American Association of Poison Control Centers (AAPCC) recorded ≈ 2,800 nicotine exposure calls per year in the U.S. (2015‑2020 data), with an upward trend paralleling the rise of vaping.

Symptoms

Symptoms of nicotine poisoning reflect stimulation of nicotinic acetylcholine receptors in the autonomic and somatic nervous systems. They appear rapidly—often within minutes of exposure—and progress through three phases: (1) stimulation, (2) paralysis, and (3) possible respiratory failure.

Early (Stimulatory) Symptoms

• Nausea & vomiting – most common early sign.
• Abdominal cramps & diarrhea – due to increased gastrointestinal motility.
• Excessive salivation (drooling) – from parasympathetic activation.
• Palpitations, tachycardia – heart rate may exceed 120 bpm.
• Hypertension – systolic BP often >140 mm Hg.
• Headache, dizziness, restlessness.
• Diaphoresis (sweating).
• Flushed, warm skin.

Intermediate (Paralytic) Symptoms

• Muscle weakness – beginning in the extremities.
• Fasciculations (muscle twitching) – especially around the face and neck.
• Bronchospasm – wheezing, shortness of breath.
• Constriction of pupils (miosis) or, paradoxically, mydriasis.
• Confusion, agitation, seizures in severe cases.

Late (Depressant) Symptoms

• Respiratory depression or failure – due to paralysis of the diaphragm.
• Bradycardia – heart rate may drop below 60 bpm after initial tachycardia.
• Hypotension – severe shock.
• Coma.

Because nicotine has a short half‑life (≈ 2 hours), symptoms typically resolve within 24 hours with appropriate care, but severe cases can be fatal within 30 minutes.

Causes and Risk Factors

Primary Sources of Nicotine Exposure

• Cigarettes and cigars – combustion releases nicotine plus many toxic by‑products.
• E‑cigarette liquids (e‑liquids) – concentrations can range from 3 mg/mL (low) to >100 mg/mL (high).
• Nicotine replacement therapy (NRT) – patches, gum, lozenges, inhalers.
• Nicotine‑containing insecticides – used in agriculture; skin absorption is possible.
• Third‑hand smoke residue on surfaces—rarely causes toxicity but can contribute in poorly ventilated spaces.

Risk Factors

• Improper storage of e‑liquids or NRT in places accessible to children.
• Use of unregulated or counterfeit vaping products that may contain nicotine concentrations far above label claims.
• Occupational exposure without gloves, goggles, or respirators.
• Underlying cardiovascular disease – nicotine’s sympathetic effects can precipitate arrhythmias.
• Pregnancy – heightened sensitivity; nicotine can cross the placenta.
• Renal or hepatic impairment – slower nicotine clearance.

Diagnosis

Diagnosis is clinical, based on a clear history of exposure and compatible signs. Laboratory testing helps confirm and gauge severity.

History & Physical Examination

• Ask about recent use of cigarettes, vaping devices, NRT, or handling of nicotine solutions.
• Determine route (oral, dermal, inhalational) and estimated amount.
• Assess vital signs: tachycardia, hypertension, respiratory rate, oxygen saturation.

Laboratory Tests

• Serum nicotine level – measured by gas chromatography–mass spectrometry; toxic range generally > 5 ng/mL, lethal > 50 ng/mL (values vary by lab).
• Cotinine – main metabolite; useful if nicotine level is already declining.
• Electrolytes, glucose, renal function – to identify secondary abnormalities.
• Arterial blood gas (ABG) – evaluates respiratory compromise.
• ECG – looks for tachyarrhythmias, ST changes.

Imaging (if indicated)

• Chest X‑ray for suspected aspiration or pulmonary edema.
• CT brain if seizures or altered mental status persist.

Reference: Mayo Clinic, CDC.

Treatment Options

Treatment focuses on decontamination, supportive care, and symptom‑directed therapy. Early intervention improves outcomes.

Immediate Management

• Airway, Breathing, Circulation (ABCs) – ensure airway patency; administer supplemental O₂.
• Activated charcoal (1 g/kg, up to 50 g) within 1 hour of ingestion to bind nicotine.
• Gastric lavage – rarely used, reserved for massive ingestion within 30 minutes and if airway protected.

Supportive Care

• Intravenous fluids – to treat hypotension and maintain urine output.
• Beta‑blockers (e.g., esmolol) – for severe tachycardia or hypertension, titrated carefully.
• Benzodiazepines (e.g., lorazepam 0.1 mg/kg) – control seizures, agitation, and muscle fasciculations.
• Anticholinergic agents (e.g., atropine) – may relieve bronchospasm and excessive secretions, but use is controversial.
• Ventilatory support – endotracheal intubation and mechanical ventilation if respiratory failure develops.

Specific Antidote

There is no FDA‑approved antidote for nicotine toxicity. Management relies on the measures above. Research is ongoing into nicotinic receptor antagonists, but they are not yet clinically available.

Observation

Patients with moderate exposure are usually monitored for 6–12 hours; severe cases may require ICU admission for 24‑48 hours.

Post‑Acute Care & Lifestyle Counseling

• Education on safe storage of nicotine products.
• Referral to smoking cessation programs if nicotine dependence is present.
• Psychiatric evaluation for intentional ingestions.

Living with Nicotinic Poisoning (Nicotine Toxicity)

Most individuals recover fully, but the experience can be frightening. Practical steps for daily life after an episode include:

• Secure all nicotine‑containing products in locked cabinets, out of reach of children and pets.
• Read labels carefully—verify nicotine concentration before use.
• Use measuring devices (syringes, droppers) provided with e‑liquids; never estimate.
• If using NRT, follow dosing instructions strictly; do not combine multiple forms (e.g., patch + gum).
• Maintain a list of emergency contacts and the local poison‑control number (US: 1‑800‑222‑1222).
• Schedule a follow‑up appointment with your primary care provider to assess any lingering cardiovascular or neurologic effects.
• Consider behavioral counseling if the incident was linked to stress, anxiety, or addiction.

Prevention

Preventing nicotine poisoning is largely about safe handling and public awareness.

• Child‑proof packaging – legislation in many countries now requires child‑resistant caps for e‑liquids and nicotine gum.
• Education for caregivers – pediatricians and schools can distribute pamphlets on the dangers of liquid nicotine.
• Proper workplace PPE – gloves, goggles, and ventilation when handling nicotine in industrial settings.
• Regulation of e‑liquid sales – age verification, limits on nicotine concentration (e.g., EU caps at 20 mg/mL for refillables).
• Safe disposal – empty cartridges and bottles in hazardous‑waste programs, not in household trash.
• Use of nicotine‑free alternatives for those who need flavoring or vapor without nicotine.

Complications

If treatment is delayed or insufficient, nicotine toxicity can lead to serious sequelae:

• Respiratory arrest – primary cause of mortality in severe cases.
• Cardiac arrhythmias – ventricular tachycardia or fibrillation.
• Acute kidney injury – from hypotension and rhabdomyolysis.
• Seizure‑related brain injury – especially with prolonged status epilepticus.
• Long‑term neurocognitive effects – rare but reported after massive overdose.
• Psychiatric sequelae – depression or anxiety after a suicide attempt.

When to Seek Emergency Care

---

Sources: Mayo Clinic, CDC Poison Center Data, American Association of Poison Control Centers, National Institute on Drug Abuse (NIDA), World Health Organization (WHO), Cleveland Clinic. All information reflects current medical consensus as of July 2026.

```